TOP2A and diffuse large B-cell lymphoma: The diagnostic validity of DLBCL biomarkers was validated by ROC analysis, and the results clearly showed that CDC6, CDC20, KIF20A, STIL, and TOP2A were specific and sensitive in diagnosing DLBCL.